Trimodality management of malignant pleural mesothelioma

被引:61
作者
Maggi, G [1 ]
Casadio, C [1 ]
Cianci, R [1 ]
Rena, O [1 ]
Ruffini, E [1 ]
机构
[1] Univ Turin, San Giovanni Battista Hosp, Dept Thorac Surg, I-10126 Turin, Italy
关键词
malignant pleural mesothelioma; pleural disease; extrapleural pneumonectomy; pleurectomy/decortication;
D O I
10.1016/S1010-7940(01)00594-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: We reviewed our experience with trimodality management of malignant pleural mesothelioma (MPM). Methods: From September 1998 to August 2000, 32 consecutive patients with histological diagnosis of MPM underwent trimodality therapy, including surgery followed by adjuvant chemotherapy and radiation therapy. Surgery consisted of pleurectomy/decortication (P/D) or pleural-pericardial-pneumonectomy and diaphragm (PPPD). Pre-operative staging according to the Brigham Staging System was accomplished using computed tomography (CT) and magnetic resonance imaging (MRI); patients with evident extrapleural spread were excluded. Results. Our series included 21 men and 11 women with a median age of 53.5 years (range 40-69). Histologically, there were 26 epithelial, four mixed and two sarcomatous MPM. Post-surgical staging was as follows: six patients were at Stage I; of these, two received a P/D and four a PPPD. Ten patients were at Stage Il and all received a PPPD; 16 patients were at Stage m (under-staged pre-operatively): of these, nine patients presented extrapleural lymph node metastases (N2) and all received a PPPD, seven patients presented with chest wall or mediastinal invasion (T4) with macroscopic residual tumour, and ail received a de-bulking P/D. We observed major complications in ten patients: six bleeding, two respiratory insufficiency and two nerve paralysis. There were two perioperative deaths (6.25% mortality). Twenty-seven patients out of 30 surviving surgery had a follow-up greater than 6 months; 21 patients out of 27 are alive with a median follow-up of 12.5 months. Conclusions: (1) Trimodality therapy is feasible in selected patients with MPM and has an acceptable operative mortality rate. (2) Our current pre-operative staging based on CT/MRI looks rather inaccurate and needs to be improved. (3) The high rate of post-surgical N2 patients or with diffusion to the inferior surface of the diaphragm may suggest the use of routine mediastinoscopy and laparoscopy for a more appropriate patient selection. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:346 / 350
页数:5
相关论文
共 16 条
  • [1] BUTCHART EG, 1976, THORAX, V22, P386
  • [2] EXTRAPLEURAL PNEUMONECTOMY FOR DIFFUSE, MALIGNANT MESOTHELIOMA
    DAVALLE, MJ
    FABER, LP
    KITTLE, CF
    JENSIK, RJ
    [J]. ANNALS OF THORACIC SURGERY, 1986, 42 (06) : 612 - 618
  • [3] *INSERM, 1996, EFF SANT PRINC TYP E
  • [4] Pleural mesothelioma in Sweden:: an analysis of the incidence according to the use of asbestos
    Järvholm, B
    Englund, A
    Albin, M
    [J]. OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 1999, 56 (02) : 110 - 113
  • [5] LAW MR, 1984, EUR J RESPIR DIS, V65, P162
  • [6] Magnani C, 1997, Med Lav, V88, P302
  • [7] MARTUZZI M, 1999, 11 C INT SOC ENV EP
  • [8] The European mesothelioma epidemic
    Peto, J
    Decarli, A
    La Vecchia, C
    Levis, F
    Negri, E
    [J]. BRITISH JOURNAL OF CANCER, 1999, 79 (3-4) : 666 - 672
  • [9] RUSCH VW, 1991, J THORAC CARDIOV SUR, V102, P1
  • [10] The importance of surgical staging in the treatment of malignant pleural mesothelioma
    Rusch, VW
    Venkatraman, E
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 111 (04) : 815 - 826